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Supplementary Figure S1.   Yeast FEN1 (scFEN1) displaces Dna2 (scDna2) 
from long double flap structures.  scDna2 (25 nM) was pre-incubated with the 
experimental 30 nt double flap substrate (U2:T3:D2.30) prior to the addition of 
increasing concentrations of scFEN1 (3.1, 6.25, 12.5, or 25 nM in lanes 3-6).  
Lane 1 shows the substrate alone, lane 2 shows scDna2 bound without scFEN1 
and lanes 7-10 show scFEN1 alone bound to the substrate at the same 
concentrations as in 3-6.  The position of the substrate alone, scDna2-substrate 
complex, and scFEN1-substrate complex are indicated to the left of the figure.	  
